Search company, investor...

Founded Year

1995

Stage

Series D | Dead

Total Raised

$17.1M

Last Raised

$8.1M

About Chase Medical

Chase Medical is developing medical technology for treating congestive heart failure. Chase Medical is developing a device called the Mannequin which aims to help the heart maintain its shape while going through reconstruction of the left ventricle.

Headquarters Location

1876 Firman Drive

Richardson, Texas, 75081,

United States

972-783-0644

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Chase Medical Patents

Chase Medical has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/15/2004

8/10/2010

Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards

Grant

Application Date

3/15/2004

Grant Date

8/10/2010

Title

Related Topics

Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards

Status

Grant

Chase Medical Frequently Asked Questions (FAQ)

  • When was Chase Medical founded?

    Chase Medical was founded in 1995.

  • Where is Chase Medical's headquarters?

    Chase Medical's headquarters is located at 1876 Firman Drive, Richardson.

  • What is Chase Medical's latest funding round?

    Chase Medical's latest funding round is Series D.

  • How much did Chase Medical raise?

    Chase Medical raised a total of $17.1M.

  • Who are the investors of Chase Medical?

    Investors of Chase Medical include Capital Southwest, First Capital Group and Red River Ventures.

  • Who are Chase Medical's competitors?

    Competitors of Chase Medical include Respicardia, Cayenne Medical, CardioKinetix, CircuLite, MiCardia and 13 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Chase Medical to Competitors

C
Cardiac Power

Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure

C
CardioKinetix

CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning membrane deployed within the compromised ventricle. The PARACHUTE partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, and decreases the overall volume. Options for patients whose ventricle has enlarged are limited, with most on medical therapy and/or a cardiac resynchronization device that only benefits heart failure patients with a specific EKG pattern.

B
Bio Control Medical

Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.

C
CardioMetrix

CardioMetrix is a medical device company developing implantable technologies to assist physicians in managing patients suffering from congestive heart failure (CHF).

JenaValve Logo
JenaValve

JenaValve develops, manufactures, and markets transcatheter aortic valve implantation systems (TAVI) to treat patients suffering from aortic valve disease. The company's transapical aortic valve system is CE-marked and currently marketed in Europe and other markets worldwide. The company was founded in 2006 and is based in Irvine, California.

Cardiac Dimensions Logo
Cardiac Dimensions

Cardiac Dimensions develops minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. Its initial technology platform, the CARILLON Mitral Contour System has been designed to address functional mitral regurgitation, utilizing a novel percutaneous approach. The company was founded in 2000 and is based in Kirkland, Washington.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.